Molina Healthcare, Inc. (MOH) Q1 2023 Earnings Call Transcript
Molina Healthcare, Inc. (NYSE:MOH) Q1 2023 Earnings Conference Call April 27, 2023 8:00 AM ET
Company Participants
Joe Krocheski - SVP, IR
Joe Zubretsky - President & CEO
Mark Keim - CFO
Conference Call Participants
Josh Raskin - Nephron Research
Stephen Baxter - Wells Fargo
Justin Lake - Wolfe Research
Nathan Rich - Goldman Sachs
Scott Fidel - Stephens
Michael Hall - Morgan Stanley
George Hill - Deutsche Bank
A.J. Rice - Credit Suisse
Calvin Sternick - JPMorgan
Sarah James - Cantor Fitzgerald
Steven Valiquette - Barclays
Gary Taylor - Cowen
Operator
Good morning, and welcome to the Molina Healthcare First Quarter 2023 Earnings Conference Call. All participants will be in listen-only mode. [Operator Instructions] After today’s presentation there will an opportunity to ask questions. [Operator Instructions] Please note, today's event is being recorded.
I would now like to turn the conference over to Joe Krocheski, Senior Vice President, Investor Relations. Please go ahead, sir.
Joe Krocheski
Good morning, and welcome to Molina Healthcare's first quarter 2023 earnings call. Joining me today are Molina's President and CEO, Joe Zubretsky; and our CFO, Mark Keim. A press release announcing our first quarter earnings was distributed after the market close yesterday and is available on our Investor Relations website.
Shortly after the conclusion of this call, a replay will be available for 30 days. The numbers to access the replay are in the earnings release. For those who listen to the rebroadcast of this presentation, we remind you that remarks made are as of today, Thursday, April 27, 2023. It has not been updated subsequent to the initial earnings call.
On this call, we will refer to certain non-GAAP measures. A reconciliation of these measures with the most directly comparable GAAP measures can be found in our first quarter 2023 press release.
During our call, we will be making certain forward-looking statements, including, but not limited to, statements regarding our 2023 guidance, Medicaid redeterminations, our recent RFP awards and related revenue growth, our acquisitions and M&A activity, our long-term growth strategy and our embedded earnings power and margins. Listeners are cautioned that all of our forward-looking statements are subject to certain risks and uncertainties that could cause our actual results to differ materially from our current expectations. We advise listeners to review the risk factors discussed in our Form 10-K annual report filed with the SEC, as well as the risk factors listed in our Form 10-Q and Form 8-K filings with the SEC.